LA JOLLA, Calif., BREDA, Netherlands and GHENT, Belgium, Oct. 4, 2012 /PRNewswire/ -- RuiYi (formerly Anaphore) and arGEN-X BV announced today that arGEN-X has granted a worldwide exclusive license to ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Anaphore today announced it has raised an additional $13 million in a second closing to its Series A Preferred Stock financing announced in January 2009, bringing ...
LA JOLLA, Calif., Dec. 13, 2010 /PRNewswire/ -- Anaphore Inc. today announced that the company has entered into a partnership with Mitsubishi Tanabe Pharma Corporation (Osaka, Japan) for the research, ...
RuiYi was founded by Raymond Stevens, PhD., of The Scripps Research Institute (TSRI) and TSRI alumni Fei Xu, Ph.D. of Shanghai, China. “The acquisition of RuiYi in China allows Anaphore to access the ...
This protein engineering firm claims its therapies, modeled on the naturally secreted human serum protein tetranectin, could compete with antibodies. With the global economy still in the throes of the ...
Anaphore Inc., a San Diego-based protein therapeutics company, has raised $8 million in VC funding from 5AM Ventures and Versant Ventures. The company was formed via the acquisition of Danish biotech ...
SAN DIEGO--(BUSINESS WIRE)--Anaphore Inc, a newly-formed protein therapeutics company located in San Diego, California, today announced an $8 Million financing round from 5AM Ventures and Versant ...
LA JOLLA, Calif.--(BUSINESS WIRE)--Anaphore today announced it has raised an additional $13 million in a second closing to its Series A Preferred Stock financing announced in January 2009, bringing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results